Although immunohistochemical studies showed increased SRGN expression in aggressive breast carcinoma 10,11, nasopharyngeal carcinoma 12, and other types of cancer 13, little is known about the diagnostic or prognostic significance of circulating SRGN in patients with cancer. The gene discussed is SRGN; the disease is nasopharyngeal carcinoma.